| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $71.6M | -35.2% |
| Cost of Revenue | $42.4M | -39.9% |
| Gross Profit | $29.2M | -26.9% |
| R&D Expense | $36.7M | +25.6% |
| SG&A Expense | $64.0M | +28.7% |
| Operating Income | -$96.0M | -39.6% |
| Interest Expense | $7.4M | -63.6% |
| Pre-tax Income | $54.9M | +153.5% |
| Income Tax | $3.6M | +2171.1% |
| Net Income | $51.3M | +149.9% |
| EPS (Basic) | $1.66 | +139.0% |
| EPS (Diluted) | $1.49 | +135.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.8M | +29.2% |
| Short-term Investments | $57.0M | — |
| Accounts Receivable | $4.2M | -65.0% |
| Current Assets | $93.8M | +1.8% |
| Total Assets | $211.0M | +9.0% |
| Current Liabilities | $72.3M | -52.3% |
| Long-term Debt | $4.6M | -95.5% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.8M | -224.2% |
| Capital Expenditures | $32.8M | +23.3% |
| Investing Cash Flow | $151.2M | +1162.4% |
| Financing Cash Flow | -$74.9M | -494.3% |
| Free Cash Flow | -$92.6M | -105.6% |
| $98.1M |
| -52.2% |
| Stockholders' Equity | $112.9M | +1066.3% |